Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 5/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.50 |
| ▸ | RAB9A | P51151 | 3/20 | 0.50 |
| ▸ | TSHR | P16473 | 2/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.50 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.47 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | PKM | P14618 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 4/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.46 |
| ▸ | MAOB | P27338 | 2/20 | 0.46 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.44 |
| ▸ | NPY1R | P25929 | 1/20 | 0.44 |
| ▸ | RECQL | P46063 | 1/20 | 0.44 |
| ▸ | NPY2R | P49146 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21424372 | 0.88 | TDP1 (0.50) | TDP1KMT2ARAB9ATSHRSMN1; SMN2 | |
| SCHEMBL21572853 | 0.86 | TDP1 (0.58) | TDP1KMT2ARAB9ATSHRSMN1; SMN2 | |
| SCHEMBL18573740 | 0.86 | RAB9A (0.48) | TDP1KMT2ARAB9ATSHRSMN1; SMN2 | |
| SCHEMBL19684946 | 0.86 | TDP1 (0.47) | TDP1KMT2ARAB9ATSHRSMN1; SMN2 | |
| SCHEMBL19928470 | 0.83 | TDP1 (0.54) | TDP1KMT2ARAB9ATSHRSMN1; SMN2 | |
| SCHEMBL26393244 | 0.83 | TDP1 (0.54) | TDP1KMT2ARAB9ATSHRSMN1; SMN2 | |
| SCHEMBL20757441 | 0.83 | TDP1 (0.47) | TDP1KMT2ARAB9ATSHRSMN1; SMN2 | |
| SCHEMBL19772868 | 0.82 | TDP1 (0.53) | TDP1KMT2ARAB9ATSHRSMN1; SMN2 | |
| SCHEMBL25541324 | 0.82 | TDP1 (0.53) | TDP1KMT2ARAB9ATSHRSMN1; SMN2 | |
| SCHEMBL17657660 | 0.81 | TDP1 (0.51) | TDP1KMT2ARAB9ATSHRSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230167067-A1 | PHOTOREDOX-CATALYZED DIRECT C-H FUNCTIONALIZATION OF ARENES | UNIV NORTH CAROLINA CHAPEL HILL (US) | 2023-06-01 | — | — | US | disclosed |
| US-20210246368-A1 | THIN FILM AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG ELECTRONICS CO LTD (KR) | 2021-08-12 | — | — | US | disclosed |
| US-10923664-B2 | Composition, thin film, and organic light emitting device including composition and thin film | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2021-02-16 | — | — | US | disclosed |
| US-20200144517-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG ELECTRONICS CO LTD (KR) | 2020-05-07 | — | — | US | disclosed |
| US-20190305229-A1 | COMPOSITION, THIN FILM, AND ORGANIC LIGHT EMITTING DEVICE INCLUDING COMPOSITION AND THIN FILM | SAMSUNG ELECTRONICS CO LTD (KR) | 2019-10-03 | — | — | US | disclosed |
| US-20180148414-A1 | PHOTOREDOX-CATALYZED DIRECT C-H FUNCTIONALIZATION OF ARENES | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL | 2018-05-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190305229-A1 | COMPOSITION, THIN FILM, AND ORGANIC LIGHT EMITTING DEVICE INCLUDING COMPOSITION AND THIN FILM | EXOC3, EXOC1, EXOC4 | TDP1 52/4885KMT2A 1215/4885RAB9A 2191/4885 |
| US-10923664-B2 | Composition, thin film, and organic light emitting device including composition and thin film | EXOC3, EXOC1, EXOC4 | TDP1 52/4885KMT2A 1215/4885RAB9A 2191/4885 |
| US-20200144517-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | CRY1, CRY2, CCNT1 | TDP1 2593/4885KMT2A 1536/4885RAB9A 2968/4885 |
| US-20180148414-A1 | PHOTOREDOX-CATALYZED DIRECT C-H FUNCTIONALIZATION OF ARENES | PPOX, AOC2, AOC3 | TDP1 2574/4885KMT2A 1406/4885RAB9A 2766/4885 |
| US-20230167067-A1 | PHOTOREDOX-CATALYZED DIRECT C-H FUNCTIONALIZATION OF ARENES | PPOX, AOC2, AOC3 | TDP1 2574/4885KMT2A 1406/4885RAB9A 2766/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.